Search





Search





Revolution Medicines Inc

RVMD

Add to Watchlist

205.755USD

-2.125-1.02%

Close 08-28 16:00（ET）

41.19BMarket Cap

LossP/E TTM

Revolution Medicines Inc

205.755

-2.125-1.02%

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

RVMD Analysis

Review the valuation, outlook, chart signals and key risks shaping Revolution Medicines Inc stock.

Revolution Medicines Doubles Pancreatic Cancer Survival in Phase 3 Trial — Is RVMD Stock a Buy at $136?

Revolution Medicines Doubles Pancreatic Cancer Survival in Phase 3 Trial — Is RVMD Stock a Buy at $136?

TradingKey - RVMD surged 41% after Phase 3 pancreatic cancer data doubled survival vs chemo. Analysts target $147–$165. Key support $125–$120. May 6 earnings next.

TradingKeyTue, Apr 14